Last update 01 Nov 2024

WXFL10203614

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
WXFL 10203614, WXFL-10203614, WXFL10203614
Target
Mechanism
JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 3
CN
31 Aug 2023
Crohn's disease, active moderatePhase 2
CN
25 Oct 2024
Crohn's disease, active severePhase 2
CN
25 Oct 2024
Ulcerative colitis, active moderatePhase 2
CN
13 Sep 2024
Ulcerative colitis, active severePhase 2
CN
13 Sep 2024
Dermatitis, AtopicPhase 2
CN
14 Aug 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
80
qcwhefqlvv(tlueekufaz) = All adverse events (AEs) were mild or moderate and resolved spontaneously. cupewkpgqj (ztuzhpiznk )
Positive
04 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free